Table 1.
Proportions of 8900 patients enrolled in a prospective screening trial for hepatocellular carcinoma with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, and severity of viral-induced liver injury
| Hepatitis type | Patients, n (%) |
|---|---|
| HBV infection | 1335 (15.0%) |
| HCV infection | 7120 (80.0%) |
| HBV + HCV infection | 445 (5.0%) |
| Hepatic parenchyma | |
| Chronic active hepatitis: mild | 5073 (57.0%) |
| Chronic active hepatitis: severe | 2225 (25.0%) |
| Cirrhosis | 1602 (18.0%) |